WO2024252375 - COMPOSITIONS OF AND METHODS OF MAKING ULTRA-PURE TRICAPRILIN
National phase entry:
Publication Number
WO/2024/252375
Publication Date
12.12.2024
International Application No.
PCT/IB2024/055663
International Filing Date
10.06.2024
Title **
[English]
COMPOSITIONS OF AND METHODS OF MAKING ULTRA-PURE TRICAPRILIN
[French]
COMPOSITIONS ET PROCÉDÉS DE FABRICATION DE TRICAPRILINE ULTRA-PURE
Applicants **
CERECIN AUSTRALIA PTY LIMITED
Level 13
41 Exhibition Street
Melbourne, Victoria 3000, AU
Inventors
LIU, Aikun Julie
Level 13
41 Exhibition Street
Melbourne, Victoria 3000, AU
Priority Data
63/472,229
09.06.2023
US
63/607,779
08.12.2023
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
IP Australia
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1895 | |
| EPO | Filing, Examination | 10589 | |
| Japan | Filing | 588 | |
| South Korea | Filing | 606 | |
| USA | Filing, Examination | 3510 |
Total: 17188 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present disclosure provides methods of producing ultra-pure tricaprilin and compositions comprising the ultra-pure tricaprilin. The disclosure also provides methods of using the compositions for the treatment of diseases.[French]
La présente divulgation concerne des procédés de production de tricapriline ultra pure et des compositions comprenant le tricapriline ultra pure. La divulgation concerne également des méthodes d'utilisation des compositions pour traiter des maladies.